Table 2.
ABOi n = 20 | ABOc n = 60 | p-value | |
---|---|---|---|
Interstitial inflammation, i | |||
i score > 0, n (%) | 5 (25) | 7 (12) | 0.58 |
Mean i score ± SD | 0.3 ± 0.57 | 0.18 ± 0.54 | |
Tubulitis, t | |||
t score > 0, n (%) | 5 (25) | 11 (18) | 0.77 |
Mean t score ± SD | 0.3 ± 0.57 | 0.23 ± 0.53 | |
Glomerulitis, g | |||
g score > 0, n (%) | 1 (5) | 4 (7) | 0.95 |
Mean g score ± SD | 0.05 ± 0.22 | 0.07 ± 0.25 | |
Capillaritis, ptc | |||
ptc score > 0, n (%) | 0 | 4 (7) | NA |
Mean ptc score ± SD | 0 | 0.08 ± 0.33 | |
Interstitial fibrosis, ci/IF | |||
ci score > 0, n (%) | 17 (85) | 31 (58) | 0.054 |
Mean ci score ± SD | 1.0 ± 0.56 | 0.53 ± 0.54 | |
Tubulus atrophy, ct/TA | |||
ct score > 0, n (%) | 18 (90) | 42 (70) | 0.14 |
Mean ct score ± SD | 1.1 ± 0.64 | 0.72 ± 0.49 | |
Intima fibrosis, cv | |||
Score > 0, n (%) | 7 (35) | 18 (30) | 0.82 |
Mean score ± SD | 0.7 ± 1.13 | 0.47 ± 0.85 | |
Arteriolar hyalinosis, ah | |||
Score > 0, n (%) | 6 (30) | 14 (23) | 0.76 |
Mean score ± SD | 0.35 ± 0.59 | 0.25 ± 0.47 | |
Transplant glomerulopathy, cg | 0 | 0 | NA |
C4d > 50%, n (%) | 15 (75) | 3 (5) | 0.002 |
C4d > 10%, n (%) | 17 (85) | 3 (5) | |
t + i > 0, n (%) | 6 (30) | 12 (20) | 0.42 |
g + ptc > 0, n (%) | 1 (5) | 5 (8) | 0.64 |
ci + ct + cv + ah > 1, n (%) | 17 (85) | 36 (60) | 0.24 |
ci + ct (IFTA) > 1 | 16 (80) | 28 (47) | 0.085 |
Subclinical rejection at one yr, n (%) | 6 (30) | 11 (18) | 0.33 |
ABMR, n (%) | 1 (5) | 0 | |
ABMR + borderline, mixed, n (%) | 0 | 4 (7) | |
Banff IA, n (%) | 0 | 2 (3) | |
Borderline, n (%) | 5 (25) | 5 (8) |
ABOi, ABO incompatible; ABOc, ABO compatible; NA, not applicable; SD, standard deviation; C4d, complement component 4d; ABMR, antibody-mediated rejection.